Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

[EPIDEMIOLOGIC ASPECTS OF HUMAN GRANULOCYTIC ANAPLASMOSIS IN THE WESTERN REGION OF UKRAINE].

Likars'ka sprava·2016
Same journal

[DEVELOPMENT OF THE LOCAL CLINICAL PATHWAY "PREVENTION OF CARDIOVASCULAR DISEASE" (SCIENTIFIC STATEMENT AND PRACTICAL APPROACH)].

Likars'ka sprava·2016
Same journal

[EXPERIMENTAL GROUNDS ON POSSIBILITY TO MAKE AND TO USE PREDICTION MODELS OF PESTICIDES DESIGN STANDARD IN THE WATER OF PONDS USED FOR HOUSEHOLD AND DRINKING WATER SUPPLY].

Likars'ka sprava·2016
Same journal

[CHANGES IN THE METABOLISM IN THE MYOCARDIUM OF RATS WITH ARTERIAL HYPERTENSION].

Likars'ka sprava·2016
Same journal

[EFFICIENCY OF COCARNIT IN COMPLEX THERAPY OF PATIENTS WITH SYSTEM DISEASES OF CONNECTING FABRIC WITH DEFEAT OF MYOCARDIUM AND DISPLAYS OF CARDIAC INSUFFICIENCY].

Likars'ka sprava·2016
Same journal

[THE CORRECTION WITH NOOPHEN OF AUTONOMIC DYSFUNCTION IN YOUNG MEN WITH HYPERTENSION].

Likars'ka sprava·2016

Related Experiment Video

Updated: May 14, 2026

A Rat Model of EcoHIV Brain Infection
08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

[Neuro-HIV: diagnostics, treatment, prophylaxis].

A S Kustkova

    Likars'Ka Sprava
    |February 5, 2013
    PubMed
    Summary

    This study details the clinical epidemiology of neurological complications of HIV infection (HIVD). Early diagnosis and specific therapy are crucial for managing HIVD and improving patient outcomes.

    Area of Science:

    • Neurology
    • Infectious Diseases
    • Epidemiology

    Context:

    • Neurological complications of Human Immunodeficiency Virus (HIV) infection, termed neuroHIV disease (neuroSPIDa), present a significant clinical challenge.
    • Understanding the epidemiology and clinical presentation of neuroSPIDa is essential for effective patient management.

    Purpose:

    • To provide a clinical and epidemiological description of neuroSPIDa.
    • To outline diagnostic and treatment strategies for common forms of neuroSPIDa.
    • To emphasize the importance of early neurological assessment in HIV-infected individuals.

    Summary:

    • The study describes the clinical and epidemiological characteristics of neuroSPIDa.
    • Recommendations for the diagnosis, management, and treatment of basic neuroSPIDa forms are presented.

    More Related Videos

    Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice
    07:23

    Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice

    Published on: December 20, 2024

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
    05:46

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

    Published on: April 9, 2014

    Related Experiment Videos

    Last Updated: May 14, 2026

    A Rat Model of EcoHIV Brain Infection
    08:48

    A Rat Model of EcoHIV Brain Infection

    Published on: January 21, 2021

    Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice
    07:23

    Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice

    Published on: December 20, 2024

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
    05:46

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

    Published on: April 9, 2014

  • The necessity of early diagnosis of neurological impairments in HIV infection is highlighted to determine the etiology and initiate timely specific therapy.
  • Impact:

    • Facilitates earlier and more accurate diagnosis of neuroSPIDa.
    • Guides clinicians in developing effective treatment plans for HIV-associated neurological disorders.
    • Aims to improve outcomes for individuals living with HIV by addressing neurological complications promptly.